|
Market Closed -
Deutsche Boerse AG
15:42:37 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 0.5750 EUR | -7.26% |
|
-15.57% | +304.93% |
| 08-24 | Valerio Therapeutics to Buy Etherna Immunotherapies in EUR30 Million Deal | MT |
| 08-17 | Valerio Therapeutics Nears Final Deal for Etherna Immunotherapies Purchase | MT |
Stock exchange
Deutsche Boerse AG
C4X 0.5750 €
-7.26%
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ALVIO | 0.5840EUR | -7.30% | 357K € | ||
Börse Stuttgart
| C4X | 0.5780EUR | -7.37% | 5.24K € | |
Deutsche Boerse AG
| C4X | 0.5750EUR | -7.26% | 0 € | |
Tradegate
| C4X | 0.5840EUR | -7.15% | 0 € | |
Boerse Muenchen
| C4X | 0.5870EUR | -7.27% | 0 € |
Quotes 5-day view: Valerio Therapeutics
Delayed Quote Deutsche Boerse AG| 2026-09-14 | 2026-09-15 | 2026-09-16 | 2026-09-17 | 2026-09-18 | |
|---|---|---|---|---|---|
| Last | €0.6600 | €0.6390 | €0.6200 | €0.6200 | €0.5750 |
| Change | -3.08% | -3.18% | -2.97% | 0.00% | -7.26% |
Performance
| 1 day | -7.26% | ||
| 1 week | -15.57% | ||
| Current month | -21.45% | ||
| 1 month | -25.71% | ||
| 3 months | +188.94% | ||
| 6 months | +492.78% | ||
| Current year | +304.93% | ||
| 1 year | +887.97% | ||
| 3 years | +122.87% | ||
| 5 years | +1.95% | ||
| 10 years | -81.47% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
291,677,807
Market Cap (USD)
334,492,898
Net sales ()
2,573,000
Net sales (USD)
2,950,688
Number of employees
25
Sales / Employee (EUR)
102,920
Sales / Employee (USD)
118,028
Free-Float
78.43%
Free-Float capitalization (EUR)
228,767,888
Free-Float capitalization (USD)
262,348,495
Average Daily Capital Traded
-.--%
Indicators
Moving average 5 days
0.6228
Moving average 20 days
0.7151
Moving average 50 days
0.6997
Moving average 100 days
0.4543
Price spread / (MMA5)
+8.31%
Price spread / (MMA20)
+24.37%
Price spread / (MMA50)
+21.69%
Price spread / (MMA100)
-20.99%
RSI 9 days
29.72
RSI 14 days
39.45
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.26% | -15.57% | +887.97% | +122.87% | 334M | ||
| +0.04% | +3.34% | +51.12% | +101.82% | 1,028B | ||
| -0.09% | +1.66% | +55.02% | +66.18% | 651B | ||
| -0.02% | +2.66% | +18.91% | +71.47% | 466B | ||
| -1.22% | +3.66% | +36.44% | +38.32% | 346B | ||
| -0.79% | +2.73% | +19.03% | +25.08% | 266B | ||
| +0.58% | +6.76% | +11.13% | +16.52% | 259B | ||
| +1.55% | +2.20% | +39.81% | +46.55% | 208B | ||
| +0.79% | +1.84% | -28.27% | -56.71% | 191B | ||
| -0.52% | +4.45% | +32.12% | +98.51% | 186B | ||
| Average | -0.54% | +3.26% | +112.33% | +53.06% | 360.21B | |
| Weighted average by Cap. | +0.23% | +3.09% | +35.23% | +61.77% |
Historical Quotes: Valerio Therapeutics
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 0.58 | 0.68 | |
| 1 month | 0.58 | 0.87 | |
| Current year | 0.09 | 0.93 | |
| 1 year | 0.04 | 0.93 | |
| 3 years | 0.03 | 0.93 | |
| 5 years | 0.03 | 0.93 | |
| 10 years | 0.03 | 5.38 |
Monthly variations
Annual variations
| 2026 | +304.93% | ||
| 2025 | +71.29% | ||
| 2024 | -45.28% | ||
| 2023 | +25.21% | ||
| 2022 | -70.34% | ||
| 2021 | -38.55% | ||
| 2020 | +29.43% | ||
| 2019 | -39.36% | ||
| 2018 | -20.93% | ||
| 2017 | -56.66% | ||
| 2016 | -32.71% | ||
| 2015 | -29.50% | ||
| 2014 | +22.30% | ||
| 2013 | -9.31% | ||
| 2012 | +47.83% | ||
| 2011 | -41.33% | ||
| 2010 | +17.61% | ||
| 2009 | +108.14% | ||
| 2008 | -83.38% | ||
| 2007 | +18.01% | ||
| 2006 | -14.36% | ||
| 2005 | -1.79% |
- Stock Market
- Stocks
- ALVIO Stock
- C4X Stock
- Quotes Valerio Therapeutics
Select your edition
All financial news and data tailored to specific country editions

















